Follow us...

 

Search News Archives

News Channels

 

New Laboratory Products

Lab News

Research & Case Studies

Microscopy | Image Analysis

Separation Science

Brochures & Literature

Videos

Events | Webinars

 

 

Conferences | Events

A fundamental breakthrough for single-cell gene expression analysis

A fundamental breakthrough for single-cell gene expression analysisAvailable from Fluidigm Europe - a recent independent feature in Technology Review Magazine calls Fluidigm's technology "a fundamental breakthrough in how researchers can interact with the biological world".

The Fluidigm BioMarkTM System revolutionizes how biologists can conduct single-cell gene expression experiments. Using microfluidic chips, the BioMark System features low input requirements and provides the sensitivity and assay throughput necessary for qPCR. Using standard TaqMan® and DNA binding dye assays, Fluidigm's proprietary Integrated Fluidic Circuit (IFC) technology enables single-cell discovery with the ability to screen hundreds of genes from single cells. Now with this unique technology it is possible to conduct up to 36,000 PCR reactions in one day, with one technician, and one BioMark System.A fundamental breakthrough for single-cell gene expression analysis

For a copy of the Technology Review Magazine feature article please contact Fluidigm Europe on +33 160 92 42 40  or email eve.marquis@fluidigm.com.

Designed for gene expression studies and digital PCR, the BioMark System sets the new standard for high-throughput real-time qPCR assays, integrating thermal cycling and fluorescence detection on Digital ArrayTM IFCs and Dynamic ArrayTM IFCs.

Fluidigm technology is based on the Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm's IFCs enable the simultaneous performance of PCR reactions in nanoliter volumes.  These "integrated circuits for biology" are made possible by miniaturizing and integrating liquid handling components on a single microfluidic device. Fluidigm's systems, consisting of instrumentation, software and single-use chips, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems.

The BioMark System consists of a real-time PCR instrument, the Dynamic Array IFCs for multiplexing the samples and reagents, as well as an IFC loader to load the IFCs.

Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology" are made possible by miniaturizing and integrating liquid handling components on a single microfluidic device. Fluidigm systems, consisting of instrumentation, software and chips, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems.


*  Fluidigm, the Fluidigm logo, BioMark, Access Array, Dynamic Array, Digital Array, FC1, Topaz, and NanoFlex are trademarks or registered trademarks of Fluidigm Corporation. All other trademarks are the property of their respective owners.


 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 


Promotions

 

Media Partners